Trinh Joanne, Tadic Vera, Klein Christine
Institute of Neurogenetics Luebeck Germany.
Mov Disord Clin Pract. 2018 Mar 23;5(2):229. doi: 10.1002/mdc3.12600. eCollection 2018 Mar-Apr.
Whole exome, genome sequencing, and other massive parallel next generation sequencing technologies have increasingly been used as a clinical diagnostic tool in recent years. Although sequencing technologies are becoming more affordable and widely used, the interpretation of variants from these large datasets at the level of personalized medicine is not clear-cut. For example, many rare missense variants identified may or may not have an impact on gene function and can be problematic to interpret in a clinical setting. Thus, there is a need for a systematic approach to applying, reporting, and evaluating variants identified. One important aspect is to determine the pathogenicity of a variant based on scientific literature. This tutorial is meant to serve as an introduction to scoring pathogenicity of variants, enabling movement disorder specialists to familiarize themselves with online tools to independently determine pathogenicity of variants identified in genetic testing reports.
近年来,全外显子测序、基因组测序以及其他大规模平行下一代测序技术越来越多地被用作临床诊断工具。尽管测序技术的成本越来越低且应用越来越广泛,但在个性化医疗层面,对这些大型数据集中变异的解读并不明确。例如,许多鉴定出的罕见错义变异可能会也可能不会对基因功能产生影响,在临床环境中进行解读可能会有问题。因此,需要一种系统的方法来应用、报告和评估鉴定出的变异。一个重要方面是根据科学文献确定变异的致病性。本教程旨在作为变异致病性评分的入门介绍,使运动障碍专家能够熟悉在线工具,从而独立确定基因检测报告中鉴定出的变异的致病性。